At a glance
ClinicalIndex Comparison Record- ✓Active diagnosis of solid or liquid cancer
- ✕Minors (under age 18) excluded from questionnaires, subject to standard of care for questionnaire assignment
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Enhanced, EHR-Facilitated Cancer Symptom Control (E2C2) Trial
In Brief
A clinical study evaluating Interview, Quality-of-Life Assessment, and 1 other intervention for Hematopoietic and Lymphoid Cell Neoplasm and Malignant Solid Neoplasm. Completed, enrolled 50,207 participants across 1 site.
Detailed Summary
This early phase I trial investigates enhanced, electronic health record (EHR)-facilitated cancer system control. Cancer and its treatment are often associated with severe, disabling symptoms that have been causally linked to diminished survival, increased healthcare utilization, degraded quality of life, unemployment, and non-adherence to recommended cancer treatments. Collaborative case management for control of moderate or worse sleep disturbance, pain, anxiety, depression, fatigue (SPADE symptoms), and physical dysfunction among cancer survivors and patients with cancer may improve quality of life, symptom severity, and adherence to cancer treatment, and may also reduce need for acute care.
Study Details
Timeline
Interventions
Participate in interview
Ancillary studies
Ancillary studies